openPR Logo
Press release

Top Pharma company in India

03-17-2011 12:28 PM CET | Health & Medicine

Press release from: Bafna Pharmaceuticals Ltd

BAFNA PHARMACEUTICALS LTD is EU - GMP, UK - MHRA, TGA Australia accredited facility in Non solid oral Dosage forms providing

consistent and unmatched service by supplying hi-end pharmaceutical formulations to Regulated Market of United Kingdom.Bafna Pharmaceuticals has expanded its

operations and set up new and improved manufacturing facilities, in Chennai, India.Bafna Pharmaceuticals has emerged as one of the most competent player in the

Contract Research And Manufacturing industry, providing consistent and unmatched service to both domestic and international markets.Good Manufacturing

Practices (GMP) approval from Ethiopia’s Drug Administration and Control Authority (DACA) for its non-betalactam facility.

Following the certification, Bafna Pharma expects to tap a huge geography of Africa, with this approval. we received Site
Approval for Loperamide capsules and Paracetamol tablets by UK, MHRA.Bafna Pharmaceuticals Ltd has already
made its presence felt in the arena of manufacturing Services in pharmaceutical Formulation domain.This plant is EU - GMP,
UK - MHRA, TGA Australia approved and is a 100% EOU.contract research and manufacturing services, Indian Drug Manufacturer, Pharmaceutical solutions

india, Top UK MHRA company in india.A strategic leader in the global pharmaceutical value chain, through dedicated efforts towards quality management and

contract research while maintaining economic viability.
Pharmaceutical formulations, Pharmaceutical & drug manufacturer, Pharmaceutical formulations development, contract
research and manufacturing services

A doyen in the industry with in-depth know-how and expertise of all the faculties & operations of the industry.Top EU - GMP
company in india, Healthcare, UK-MHRA, EU-GMP, Quality Products In Pharma Industry, Pharmaceutical formulations development,Global pharmaceutical

companies, Pharmaceutical companies in India A doyen in the industry with in-depth know-how and expertise of all the faculties & operations of the industry.

Pharmaceuticals Exporters, Top Pharma company in India ,Top Pharma Company in Chennai, , Top Pharma Company in Asia, Indian Pharmaceutical Industry,

Pharmaceutical formulations, Pharmaceutical companies in India

BAFNA PHARMACEUTICALS LTD is EU - GMP, UK - MHRA, TGA Australia accredited facility in Non solid oral Dosage forms providing

consistent and unmatched service by supplying hi-end pharmaceutical formulations to Regulated Market of United Kingdom.

Bafna Pharmaceuticals Ltd
Bafna Towers
299, Thambu Chetty street,
Chennai - 600 001.
Tamilnadu
India.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Pharma company in India here

News-ID: 166958 • Views: …

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDΒ 22.32Β Billion by 2024. The valuation is expected to reach USDΒ 47.79Β Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…